Literature DB >> 16195228

Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein.

Virginie Sandrin1, François-Loïc Cosset.   

Abstract

Retroviral Gag and Env glycoproteins (GPs) are expressed from distinct cellular areas and need to encounter to interact and assemble infectious particles. Retroviral particles may also incorporate GPs derived from other enveloped viruses via active or passive mechanisms, a process known as "pseudotyping." To further understand the mechanisms of pseudotyping, we have investigated the capacity of murine leukemia virus (MLV) or lentivirus core particles to recruit GPs derived from different virus families: the G protein of vesicular stomatitis virus (VSV-G), the hemagglutinin from an influenza virus, the E1E2 glycoproteins of hepatitis C virus (HCV-E1E2), and the retroviral Env glycoproteins of MLV and RD114 cat endogenous virus. The parameters that influenced the incorporation of viral GPs onto retroviral core particles were (i) the intrinsic cell localization properties of both viral GP and retroviral core proteins, (ii) the ability of the viral GP to interact with the retroviral core, and (iii) the expression of the lentiviral Nef protein. Whereas the hemagglutinin and VSV-G glycoproteins were recruited by MLV and lentivirus core proteins at the cell surface, the HCV and MLV GPs were most likely recruited in late endosomes. In addition, whereas these glycoproteins could be passively incorporated on either retrovirus type, the MLV GP was also actively recruited by MLV core proteins, which, through interactions with the cytoplasmic tail of the latter GP, induced its localization to late endosomal vesicles. Finally, the expression of Nef proteins specifically enhanced the incorporation of the retroviral GPs by increasing their localization in late endosomes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195228     DOI: 10.1074/jbc.M506070200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.

Authors:  Yul Eum Song; Grace Y Olinger; Sanath Kumar Janaka; Marc C Johnson
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

2.  Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions.

Authors:  Devon A Gregory; Terri D Lyddon; Marc C Johnson
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

3.  Hepatitis C virus entry depends on clathrin-mediated endocytosis.

Authors:  Emmanuelle Blanchard; Sandrine Belouzard; Lucie Goueslain; Takaji Wakita; Jean Dubuisson; Czeslaw Wychowski; Yves Rouillé
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Two distinct mechanisms regulate recruitment of murine leukemia virus envelope protein to retroviral assembly sites.

Authors:  Tiffany M Lucas; Terri D Lyddon; Sarah A Grosse; Marc C Johnson
Journal:  Virology       Date:  2010-07-23       Impact factor: 3.616

5.  Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages.

Authors:  George B Kyei; Christina Dinkins; Alexander S Davis; Esteban Roberts; Sudha B Singh; Chunsheng Dong; Li Wu; Eiki Kominami; Takashi Ueno; Akitsugu Yamamoto; Maurizio Federico; Antonito Panganiban; Isabelle Vergne; Vojo Deretic
Journal:  J Cell Biol       Date:  2009-07-27       Impact factor: 10.539

6.  Function of ubiquitin (Ub) specific protease 15 (USP15) in HIV-1 replication and viral protein degradation.

Authors:  Dohun Pyeon; Khalid Amine Timani; Fahad Gulraiz; Johnny J He; In-Woo Park
Journal:  Virus Res       Date:  2016-07-25       Impact factor: 3.303

7.  Nef modulates the immunogenicity of Gag encoded in a non-infectious HIV DNA vaccine.

Authors:  Geraldine Arrode; Ramakrishna Hegde; Yuhuai Jin; Dinesh Kumar Singh; Opendra Narayan; Yahia Chebloune
Journal:  Vaccine       Date:  2008-06-17       Impact factor: 3.641

8.  Human immunodeficiency virus type 1 and influenza virus exit via different membrane microdomains.

Authors:  Sandhya Khurana; Dimitry N Krementsov; Aymeric de Parseval; John H Elder; Michelangelo Foti; Markus Thali
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

9.  Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.

Authors:  Charles R Langelier; Virginie Sandrin; Debra M Eckert; Devin E Christensen; Viswanathan Chandrasekaran; Steven L Alam; Christopher Aiken; John C Olsen; Alak Kanti Kar; Joseph G Sodroski; Wesley I Sundquist
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

10.  Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors.

Authors:  Ilias Christodoulopoulos; Magali E Droniou-Bonzom; Jill E Oldenburg; Paula M Cannon
Journal:  Retrovirology       Date:  2010-01-26       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.